WYNN
45
-3
PSX
57
-7
FDX
48
-2
MTCH
53
2
NOV
40
-2
NRG
55
-4
PM
52
2
ED
45
3
HST
52
-2
ROK
71
3
PEG
39
2
MCO
59
3
AMZN
51
-2
D
48
3
FSLR
44
-6
PCG
50
5
LB
69
59
CNP
62
12
VMC
60
-2
AVGO
40
-2
WYNN
45
-3
PSX
57
-7
FDX
48
-2
MTCH
53
2
NOV
40
-2
NRG
55
-4
PM
52
2
ED
45
3
HST
52
-2
ROK
71
3
PEG
39
2
MCO
59
3
AMZN
51
-2
D
48
3
FSLR
44
-6
PCG
50
5
LB
69
59
CNP
62
12
VMC
60
-2
AVGO
40
-2
Financhill
Back

Novo Nordisk AS Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26

NVO
Novo Nordisk AS

Last Price:
$65.80
Seasonality Move:
0.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 18.5% based on the past 44 years of stock performance.
  • Novo Nordisk AS has risen higher in 30 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 68.18%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NVO] share price is $67.04. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 18.5% based on the past 44 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 30 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 68.18%

Novo Nordisk AS Stock Price History

Is NVO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
139.74
52-Week Low:
57.00

Prediction Charts

Market Cap:
297.9B
Price in USD:
67.04
Volume:
5.6M
Beta:
0.49

Technical Analysis

SMA50:
70.22
SMA100:
71.70
SMA200:
86.09
52-Wk Change:
-52.41%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 67.04 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 67.62 67.70 68.38 67.19
Jun-27 68.76 68.51 68.94 67.98
Jun-30 69.43 69.02 69.55 68.54
Jul-1 68.41 69.82 70.42 68.12
Jul-2 69.56 69.82 70.33 68.90
Jul-3 69.28 69.17 69.40 68.58
Jul-7 69.36 69.32 69.54 68.71
Jul-8 69.45 69.64 70.61 68.65
Jul-9 68.99 69.69 69.87 68.86
Jul-10 69.58 71.01 71.75 69.52
Jul-11 69.74 68.93 69.89 68.53
Jul-14 68.60 68.94 69.55 68.48
Jul-15 69.49 67.22 69.49 66.71
Jul-16 67.34 67.04 68.04 66.99

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.10 per share, an increase this year of $1.01 per share, and an increase next year of $0.54 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.